What Does Rising Demand For Sterile Fill-Finish Services Mean For The Future Of Outsourcing
What Does Rising Demand For Sterile Fill-Finish Services Mean For The Future Of Outsourcing
Sponsored by:
Sponsored by:
More from Manufacturing
• By
50% tariffs on US imports from India, a range on others, an uncertain outcome of Section 232 investigations of pharma and talk of BRICS tariffs are making forecasting for the pharma industry extremely difficult, Scrip finds in this infographic analysis
• By
Celltrion is set to acquire a US biologics manufacturing facility that will "eliminate" its US tariff risks and provide a ready-made production base for future expansion.
• By
A single 15% tariff rate on imports from Europe includes pharmaceuticals, but it remains unclear if the trade deal will exclude generics or if Trump will offer a grace period.
• By
The drugmaker plans to build a large manufacturing center in Virginia as the centerpiece of an effort to invest $50bn in the US by 2030.
More from Business
Sponsored by:
Learn how advances in vaccine adjuvants are shaping the future of global health and driving more effective immunization strategies
Sponsored by:
Learn how advances in vaccine adjuvants are shaping the future of global health and driving more effective immunization strategies
Sponsored by:
Insights from Novotech on Evolving Trends Impacting Global Clinical Development
Sponsored by:
Lonza is addressing the growing global demand for biologics by utilizing its expert teams and the advanced capabilities of its newly acquired large-scale manufacturing site in Vacaville, California. Joanna McCafferty, Director of Commercial Development, shares more in this brief video. Ask ChatG